Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone - PubMed

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

A Adachi et al. J Virol. 1986 Aug.

Abstract

We constructed an infectious molecular clone of acquired immunodeficiency syndrome-associated retrovirus. Upon transfection, this clone directed the production of infectious virus particles in a wide variety of cells in addition to human T4 cells. The progeny, infectious virions, were synthesized in mouse, mink, monkey, and several human non-T cell lines, indicating the absence of any intracellular obstacle to viral RNA or protein production or assembly. During the course of these studies, a human colon carcinoma cell line, exquisitely sensitive to DNA transfection, was identified.

Similar articles

• AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts.

  Levy JA, Cheng-Mayer C, Dina D, Luciw PA. Levy JA, et al. Science. 1986 May 23;232(4753):998-1001. doi: 10.1126/science.3010461. Science. 1986. PMID: 3010461

• A molecular clone of HTLV-III with biological activity.

  Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F. Fisher AG, et al. Nature. 1985 Jul 18-24;316(6025):262-5. doi: 10.1038/316262a0. Nature. 1985. PMID: 2410792

• Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

  De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F. De Rossi A, et al. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4297-301. doi: 10.1073/pnas.83.12.4297. Proc Natl Acad Sci U S A. 1986. PMID: 2424024 Free PMC article.

• Lymphadenopathy-associated-virus infection and acquired immunodeficiency syndrome.

  Gluckman JC, Klatzmann D, Montagnier L. Gluckman JC, et al. Annu Rev Immunol. 1986;4:97-117. doi: 10.1146/annurev.iy.04.040186.000525. Annu Rev Immunol. 1986. PMID: 3011034 Review. No abstract available.

• Molecular biology of human T-lymphotropic retroviruses.

  Wong-Staal F, Ratner L, Shaw G, Hahn B, Harper M, Franchini G, Gallo R. Wong-Staal F, et al. Cancer Res. 1985 Sep;45(9 Suppl):4539s-4544s. Cancer Res. 1985. PMID: 2990683 Review.

Cited by

• Cytotoxic cell populations developed during treatment with tyrosine kinase inhibitors protect autologous CD4+ T cells from HIV-1 infection.

  Vigón L, Rodríguez-Mora S, Luna A, Sandonís V, Mateos E, Bautista G, Steegmann JL, Climent N, Plana M, Pérez-Romero P, de Ory F, Alcamí J, García-Gutierrez V, Planelles V, López-Huertas MR, Coiras M. Vigón L, et al. Biochem Pharmacol. 2020 Dec;182:114203. doi: 10.1016/j.bcp.2020.114203. Epub 2020 Aug 20. Biochem Pharmacol. 2020. PMID: 32828803 Free PMC article.

• Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.

  Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Caskey M, Robbiani DF, Nussenzweig MC, Rice CM, Hatziioannou T, Bieniasz PD. Schmidt F, et al. J Exp Med. 2020 Nov 2;217(11):e20201181. doi: 10.1084/jem.20201181. J Exp Med. 2020. PMID: 32692348 Free PMC article.

• Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation.

  Soto-Rifo R, Limousin T, Rubilar PS, Ricci EP, Décimo D, Moncorgé O, Trabaud MA, André P, Cimarelli A, Ohlmann T. Soto-Rifo R, et al. Nucleic Acids Res. 2012 Mar;40(6):2653-67. doi: 10.1093/nar/gkr1093. Epub 2011 Nov 24. Nucleic Acids Res. 2012. PMID: 22121214 Free PMC article.

• Distinct Gag interaction properties of HIV-1 RNA 5' leader conformers reveal a mechanism for dimeric genome selection.

  Yang X, Liu Y, Cui W, Liu M, Wang W. Yang X, et al. RNA. 2023 Feb;29(2):217-227. doi: 10.1261/rna.079347.122. Epub 2022 Nov 16. RNA. 2023. PMID: 36384962 Free PMC article.

• Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load.

  Kramer VG, Schader SM, Oliveira M, Colby-Germinario SP, Donahue DA, Singhroy DN, Tressler R, Sloan RD, Wainberg MA. Kramer VG, et al. Antimicrob Agents Chemother. 2012 Aug;56(8):4154-60. doi: 10.1128/AAC.00409-12. Epub 2012 May 21. Antimicrob Agents Chemother. 2012. PMID: 22615275 Free PMC article.

References

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • LANL HIV Databases